Capital Advisors »

Merrimack Pharma shares owned by Capital Advisors

Quarter-by-quarter ownership of Merrimack Pharma (MACK) shares owned by Capital Advisors from 13F filings

Historical chart of Capital Advisors investment in Merrimack Pharma

Tip: Access up to 7 years of quarterly data

All positions including Merrimack Pharma held by Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merrimack Pharma by Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $0 28 0.00

More positions owned by Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Grw Etf (IWF)
Caesars Entertainment (CZR)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Rus 1000 Val Etf (IWD)
Ishares Tr Msci Usa Min Vol (USMV)
Ishares Tr S&p Mc 400gr Etf (IJK)
Spdr Ser Tr S&p Divid Etf (SDY)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core Div Grwth (DGRO)
Ishares Tr S&p Mc 400vl Etf (IJJ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Ishares Tr S&p 500 Grwt Etf (IVW)

View all positions for Capital Advisors

Top funds holding Merrimack Pharma

Western Standard
Newtyn Management
BlackRock
Vanguard Group
Madison Avenue Partners
ADAR1 Capital Management
Dimensional Fund Advisors
Sepio Capital
Indaba Capital Management
Wittenberg Investment Management
Caption Management
Bank of New York Mellon
Susquehanna International
Kennedy Capital Management
Goldman Sachs Group

View all funds holding Merrimack Pharma